These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 2430365

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
    Smid WM, Martens A, van der Meer J, Hegge-Paping CS, Halie MR.
    Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Abnormal T-cell subpopulations in hemophilic patients receiving factor VIII concentrates from voluntary donors.
    Wearne A, Joshua DE, Rickard KA, Kronenberg H.
    Aust N Z J Med; 1984 Apr; 14(2):149-53. PubMed ID: 6236788
    [Abstract] [Full Text] [Related]

  • 8. A study of lymphocyte populations and subpopulations in hemophiliacs and their relationships with age and consumption of lyophilized factor VIII concentrates.
    Aznar JA, Carbonell F, Jorquera JI, Carmona E, Sánchez-Cuenca JM, Trénor A, de Andrés-Medina R, González-Molina A.
    Ric Clin Lab; 1985 Apr; 15(4):315-21. PubMed ID: 3938863
    [Abstract] [Full Text] [Related]

  • 9. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
    White GC, Greenwood R, Escobar M, Frelinger JA.
    Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of factor VIII concentrate on antigen-presenting cell (APC)/T-cell interactions in vitro: relevance to inhibitor formation and tolerance induction.
    Hodge G, Han P.
    Br J Haematol; 2000 Apr; 109(1):195-200. PubMed ID: 10848800
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of human T cell responses to allogeneic stimuli by factor VIII concentrates.
    Batchelor A, Steel CM, Ludlam CA.
    Br J Haematol; 1992 Sep; 82(1):94-8. PubMed ID: 1419808
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
    Hayashi T, Niiya K, Sakuragawa N, Ichihara K, Yamazaki T, Watanabe A.
    Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J, McDougal JS, Holman RC, Stein SF, Lawrence DN, Nicholson JK, Dixon G, Doxey M, Evatt BL.
    JAMA; 1985 Jun 21; 253(23):3409-15. PubMed ID: 2987559
    [Abstract] [Full Text] [Related]

  • 18. Absence of VIII AHF response to adrenalin in hemophilia A.
    Eyster ME, Dranchak M, Haverstick J, Rogers JS.
    Am J Hematol; 1977 Jun 21; 3():193-8. PubMed ID: 602937
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.